About AcuFocus
AcuFocus is a company based in Irvine (United States) founded in 2001 was acquired by Bausch & Lomb in January 2023. AcuFocus has raised $219.07 million across 14 funding rounds from investors including Medtronic, Bausch & Lomb and KKR. The company has 27 employees as of December 31, 2022. AcuFocus offers products and services including Stellaris Elite, enVista, Bi-Blade, TENEO, and Cohen-Benner Contact Lens. AcuFocus operates in a competitive market with competitors including Bausch & Lomb, Dopavision, Appasamy Associates, Katalyst Surgical and Lamellar, among others.
- Headquarter Irvine, United States
- Employees 27 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Acufocus, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$219.07 M (USD)
in 14 rounds
-
Latest Funding Round
Not available
-
Investors
Medtronic
& 10 more
-
Employee Count
27
as on Dec 31, 2022
-
Acquired by
Bausch & Lomb
(Jan 17, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AcuFocus
AcuFocus offers a comprehensive portfolio of products and services, including Stellaris Elite, enVista, Bi-Blade, TENEO, and Cohen-Benner Contact Lens.
Vision enhancement system for dual-function surgical platforms.
Lens for vision correction in cataract procedures.
Tool for precise retinal surgery and tissue removal.
Laser system for refractive eye surgery applications.
Lens for posterior visualization during eye operations.
People of AcuFocus
Unlock access to complete
Unlock access to complete
Funding Insights of AcuFocus
AcuFocus has successfully raised a total of $219.07M across 14 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AcuFocus
AcuFocus has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic, Bausch & Lomb and KKR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Flying L Partners is focused on ophthalmic sector investments.
|
Locked | Locked | Locked | |
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked | |
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Locked | Locked | Locked |
Investor details for AcuFocus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AcuFocus
Investment portfolio details for AcuFocus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AcuFocus
Detailed financials for AcuFocus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acufocus Comparisons
Peer comparison for AcuFocus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AcuFocus
AcuFocus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bausch & Lomb, Dopavision, Appasamy Associates, Katalyst Surgical and Lamellar, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ophthalmic pharmaceuticals and instruments are developed for eye care.
|
|
| Locked | Locked | Locked |
Digital therapeutics for myopia are developed via retinal light stimulation.
|
|
| Locked | Locked | Locked |
Ophthalmic instruments and pharmaceutical products are developed for eye care.
|
|
| Locked | Locked | Locked |
Titanium ophthalmic surgical instruments are manufactured and repaired.
|
|
| Locked | Locked | Locked |
Develops patented medical devices and pharmaceuticals based on mimetics of extra-alveolar lamellar bodies
|
|
| Locked | Locked | Locked |
Precision instruments for eye surgery are designed and manufactured.
|
Detailed competitors of AcuFocus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acufocus
Complete news archive for AcuFocus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AcuFocus
AcuFocus was founded in 2001 and raised its 1st funding round 1 year after it was founded.
AcuFocus is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Alan Waterhouse is the current CEO of AcuFocus.
AcuFocus is a funded company, having raised a total of $219.07M across 14 funding rounds to date.
As of Dec 31, 2022, the latest employee count at AcuFocus is 27.
Developer of small aperture technology-based ophthalmic devices. The platform uses the pinhole effect to bring objects into focus. Two products have been developed - KAMRA corneal inlay for presbyopia and IC-8 intraocular lens for cataract. Also, has a diagnostic and surgical planning instrument AcuTarget HD.
AcuFocus's top competitors include Bausch & Lomb, Appasamy Associates and Katalyst Surgical.
AcuFocus offers Stellaris Elite, enVista, Bi-Blade, TENEO, and Cohen-Benner Contact Lens.
AcuFocus has 11 investors. Key investors include Medtronic, Bausch & Lomb, KKR, The Carlyle Group, and Flying L Partners.